LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® iX Absorbable Hemostat has been granted the Class III CE Mark certification for internal wounds. Already in medical markets overseas as a surface wound hemostat, BloodSTOP® iX will now be offered to the...
LifeScience PLUS today announced the introduction of its proven fast-acting BloodSTOP hemostatic products in global markets. The company’s patent pending hemostatic technology brings a new level of efficacy to the wound care market.
LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® has been granted the Class IIb CE Mark certification for the control of bleeding from all surface wounds. “We are pleased to be able to extend our markets for this breakthrough product beyond the US and...
